Article
Biological and clinical consequences of NPM1 mutations in AML.
Leukemia - 1 Apr 2017
Heath E M, Chan S M, Minden M D, Murphy T, Shlush L I, Schimmer A D
Abstract excerpt
Acute myeloid leukemia (AML) is characterized by accumulation of myeloid cells in the bone marrow because of impaired differentiation and proliferation, resulting in hematopoietic insufficiency. NPM1 is one of the most commonly mutated genes in AML, present in 20-30% of cases. Mutations in NPM1 represent a distinct entity in the World Health Organization (WHO) classification and commonly indicate a better risk...
Topics
- Biomarkers, Tumor
- Cell Transformation, Neoplastic
- Clinical Decision-Making
- Epistasis, Genetic
- Gene Expression Regulation, Leukemic
- Gene Frequency
- Humans
- Leukemia, Myeloid, Acute
- Mutation
- Neoplasm, Residual
- Nuclear Proteins